Overview

Effects of a Genistein Concentrated Polysaccharide (GCP) for Prostate Cancer on Active Surveillance.

Status:
Completed
Trial end date:
2007-12-01
Target enrollment:
Participant gender:
Summary
Genistein Combined Polysaccharide (GCP) may play a role as a secondary chemopreventive agent in the treatment of localized prostate cancer.
Phase:
Phase 2/Phase 3
Details
Lead Sponsor:
University of California, Davis
Treatments:
Genistein